Panagene Inc
KOSDAQ:046210
Panagene Inc
Research & Development
Panagene Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Panagene Inc
KOSDAQ:046210
|
Research & Development
-₩3.8B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-49%
|
Celltrion Inc
KRX:068270
|
Research & Development
-₩157.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-21%
|
|
SK Bioscience Co Ltd
KRX:302440
|
Research & Development
-₩85.7B
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Research & Development
-₩10.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Research & Development
-₩15B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
A
|
Alteogen Inc
KOSDAQ:196170
|
Research & Development
-₩25.3B
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
See Also
What is Panagene Inc's Research & Development?
Research & Development
-3.8B
KRW
Based on the financial report for Dec 31, 2023, Panagene Inc's Research & Development amounts to -3.8B KRW.
What is Panagene Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-49%
Over the last year, the Research & Development growth was -13%. The average annual Research & Development growth rates for Panagene Inc have been -28% over the past three years , -21% over the past five years , and -49% over the past ten years .